Hogy Medical Co Ltd 2023 IR
The report highlights HOGY Medical's performance and initiatives for the fiscal year ended March 31, 2023. The company achieved consolidated net sales of 38,981 million yen, driven by strong sales of its Premium Surgical Kit. HOGY Medical launched its Single-Use Device Remanufacturing (R-SUD) business under the 'REVICE' brand to promote resource efficiency and reduce medical waste. In sustainability, the company advanced its 'Eco Project for the Firefly' and increased its hybrid vehicle fleet to 85.3%. Additionally, the company established a Sustainability Committee and introduced a restricted stock unit plan to enhance corporate governance.
Company: Hogy Medical Co Ltd
Sector: Health Care
Country: Japan
Year: 2023
Type: IR
Pages: 42
Hogy Medical Co Ltd
Corporate Report
The report highlights HOGY Medical's performance and initiatives for the fiscal year ended March 31, 2023. The company achieved consolidated net sales of 38,981 million yen, driven by strong sales of its Premium Surgical Kit. HOGY Medical launched its Single-Use Device Remanufacturing (R-SUD) business under the 'REVICE' brand to promote resource efficiency and reduce medical waste. In sustainability, the company advanced its 'Eco Project for the Firefly' and increased its hybrid vehicle fleet to 85.3%. Additionally, the company established a Sustainability Committee and introduced a restricted stock unit plan to enhance corporate governance.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2023
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women in Management
Employees